Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Regenerative Medicine Market: By Technology: Stem Cell Therapy, Biomaterial, Tissue Engineering, Other; By Application: Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments

Global Regenerative Medicine Market Outlook

The global regenerative medicine market attained a value of USD 2.80 million in 2020 and is expected to grow at a CAGR of 11.7% during the forecast period of 2023-2028 owing to increased investment by companies in R&D.

 

Global Regenerative Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Regenerative medicine is a branch of tissue engineering and molecular biology that deals with the method of replacing, regenerating human cells, tissues and organs to restore ordinary function. Regenerative medicine is widely used for bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, central nervous system, and others.

 

Global Regenerative Medicine Market By Technology

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The regenerative medicine market is segmented based on technology into:

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Other

The EMR report looks further into the regional regenerative medicine markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.

 

Global Regenerative Medicine Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global regenerative medicine market is being driven by high number of clinical trials, growing impact of economy on regenerative medicine, emerging applications of gene therapy in regenerative medicine, increasing funding of government and private sectors to support the development of regenerative medicine, and technological advances in stem cell, tissue engineering, and nanotechnology. The regenerative medicine market is further driven by rising strategic partnership that helps in accelerating commercialisation of regenerative medicine. Rising prevalence of chronic diseases and genetic disorders, degenerative diseases, and bone and joint diseases are other factors leading to rise in demand for regenerative treatments. The high cost of treatment, and regulatory issues pertaining to stem cells, tissues engineering and regenerative medicine, are factors that might hinder the growth of the industry.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the regenerative medicine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Novartis AG 
  • Vericel Corporation
  • Stryker Corporation
  • Integra LifeSciences Corporation.
  • Mimedx Group Inc.
  • Wright Medical Group N.V.

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Technology, Application, Region
Breakup by Technology Stem Cell Therapy, Biomaterial, Tissue Engineering, Other
Breakup by Application Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, Other Applications
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Regenerative Medicine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Regenerative Medicine Historical Market (2018-2022) 
    8.3    Global Regenerative Medicine Market Forecast (2023-2028)
    8.4    Global Regenerative Medicine Market by Technology
        8.4.1    Stem Cell Therapy
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Biomaterials
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Tissue Engineering
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Others
    8.5    Global Regenerative Medicine Market by Application
        8.5.1    Bone Graft Substitutes
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Osteoarticular Diseases
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Dermatology
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Cardiovascular
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Central Nervous System
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2018-2022)
            8.5.5.3    Forecast Trend (2023-2028)
        8.5.6    Others
    8.6    Global Regenerative Medicine Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Company Profiles
        13.2.1    Novartis AG
            13.2.1.1    Company Overview
            13.2.1.2    Product Portfolio
            13.2.1.3    Demographic Reach and Achievements
            13.2.1.4    Certifications
        13.2.2    Vericel Corporation
            13.2.2.1    Company Overview
            13.2.2.2    Product Portfolio
            13.2.2.3    Demographic Reach and Achievements
            13.2.2.4    Certifications
        13.2.3     Stryker Corporation
            13.2.3.1    Company Overview
            13.2.3.2    Product Portfolio
            13.2.3.3    Demographic Reach and Achievements
            13.2.3.4    Certifications
        13.2.4    Integra LifeSciences Corporation.
            13.2.4.1    Company Overview
            13.2.4.2    Product Portfolio
            13.2.4.3    Demographic Reach and Achievements
            13.2.4.4    Certifications
        13.2.5    Mimedx Group Inc.
            13.2.5.1    Company Overview
            13.2.5.2    Product Portfolio
            13.2.5.3    Demographic Reach and Achievements
            13.2.5.4    Certifications
        13.2.6    Wright Medical Group N.V.
            13.2.6.1    Company Overview
            13.2.6.2    Product Portfolio
            13.2.6.3    Demographic Reach and Achievements
            13.2.6.4    Certifications
        13.2.7    Others
14    Industry Events and Developments


List of Key Figures and Tables

1.    Global Regenerative Medicine Market: Key Industry Highlights, 2018 and 2028
2.    Global Regenerative Medicine Historical Market: Breakup by Technology (USD Million), 2018-2022
3.    Global Regenerative Medicine Market Forecast: Breakup by Technology (USD Million), 2023-2028
4.    Global Regenerative Medicine Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Regenerative Medicine Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Regenerative Medicine Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Regenerative Medicine Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Regenerative Medicine Market Structure

Key Questions Answered in the Report

In 2020, the global regenerative medicine market attained a value of nearly USD 2.80 million.

The market is projected to grow at a CAGR of 11.7% between 2023 and 2028.

The major drivers of the industry such as emerging uses of gene therapy, rising prevalence of chronic diseases and genetic disorders, favourable government policies, and increased funding from various organisations are aiding the industry growth.

The key market trends guiding the growth of the industry include technological advancements in the field of stem cell, tissue engineering, and nanotechnology and high number of clinical trials.

The major regional markets are North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa.

Stem cell therapy, biomaterial, and tissue engineering, among others are the major technologies of industry.

Bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others are the major applications of regenerative medicine.

The major players in the industry are Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.

Analyst Review

The global regenerative medicine market attained a value of USD 2.80 million in 2020 driven by the increasing number of clinical trials. Aided by technological advancements in biotechnology and nanotechnology, and favourable government policies, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 11.7%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on technology, the industry can be segmented into stem cell therapy, biomaterial, and tissue engineering, among others. On the basis of application, the industry can be segmented into bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others. The major regional markets for the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER